Laddar populära aktier...
Redeye returns with a positive view on the back of Bredband2’s Q1 2024 report posting solid growth a...
Seamless Distribution Systems (”SDS” eller ”bolaget”) publicerade den 3 maj 2024 bolagets delårsrapp...
Permit for Viscaria granted, a major milestone Permit allows for 3.
Redeye comments on Salénterprise’s mandatory bid of all shares in NeoDynamics for SEK1.
Sales in line, but EBITA +4% vs. ABGSCe Lower opex and better customer intake than expected Expect c...
Redeye leaves a short comment following Lipum’s announcement of a loan commitment of SEK20m with Fle...
Analyst Group has entered into an agreement with ODI Pharma on commissioned research, including e.
Raute’s Q1 showed how Wood Processing is to return to black after a string of challenging years.
Setanaxib delivers promising results when used together with Keytruda in a tumour type, where Setana...
Decelerating org. growth but strong cash flow '24e-'26e adj.
Redeye provides its initial comments on Catella's Q4 2023 report, which came in moderately below our...
Redeye makes some minor estimate changes following the report (lowering sales from TUBEX in Africa),...
VibroSense redovisade en nettoomsättning om 0,5 MSEK (0,5) i kvartalet, vilket var en minskning med ...
Ascelia achieved the vital objective to secure a re-reader evaluation of SPARKLE by May 2024.
Redeye states the report was below expecations across the board.